TKNO

Alpha Teknova (TKNO) shares rose 5.1% to $6.15 after announcing robust preliminary Q3 2026 financial results with revenues expected between $12.5-$12.7 million. Despite the rally, the stock remains down 34.5% over the past four weeks.

The company is expected to post a quarterly loss of $0.06 per share with revenues up 12% year-over-year. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the recent jump may lack sustained momentum.

Alpha Teknova (TKNO) announced it will report third quarter 2026 financial results on November 4, 2026, followed by a webcast and conference call at 6:00 p.m. ET. The company, a producer of critical reagents for life sciences, also recently announced a $40 million public offering of common stock.

Alpha Teknova (TKNO) announced the pricing of an underwritten public offering of 8 million shares at $5.00 per share, generating $40 million in gross proceeds. The offering is expected to close on October 22, 2026. Teknova intends to use net proceeds for general corporate purposes, including potential debt repayment and strategic acquisitions.